Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 525

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 525
---
 company controlled by Mr. Knuettel, the Company’s Chief Executive Officer and Chief Financial Officer, entered converted certain payables into a promissory note for $131,868. The note matures on December 15, 2024, or, if earlier to occur, upon the closing of a public or private offering or other financing or capital-raising transaction of any kind. As of December 31, 2024, the note was in default, though the Company has not received any notice from Mr. Knuettel. The note accrued interest at the rate of 4.86% per annum through December 15, 2024 and 6.86% thereafter. As of December 31, 2024, the note had an outstanding principal of $131,868 and accrued interest of $4,242. Outstanding Principal on Related Party Notes

| Note Payable - Related Party  |     | Outstanding 
   Principal |     | Unamortized   
 Debt Discount |     |       Outstanding 
 Principal, net of 
     Debt Discount |
| Related Party Note            |     |    $131,868 |     | $—            |     |          $131,868 |
| Total as of December 31, 2024 |     |    $131,868 |     | $—            |     |          $131,868 |

F-35

TABLE OF CONTENTS

| Note Payable - Related Party          |     | Outstanding 
   Principal |     |   Unamortized 
 Debt Discount |     |       Outstanding 
 Principal, net of 
     Debt Discount |
| Director Note                         |     |    $175,000 |     |            $— |     |          $175,000 |
| September and April Bridge financings |     |     596,928 |     |       -21,846 |     |           575,082 |
| Total as of December 31, 2023         |     |    $771,928 |     |     $(21,846) |     |          $750,082 |

NOTE 5 - NOTES PAYABLE Investor Note On February 4, 2022, the Company entered into a note payable for $450,000 (the “Investor Note”) with a third party. This Investor Note had an original issuance discount of $150,000, representing an implicit interest rate of 50%, a maturity date of February 3, 2023, and accrues no interest beyond the original issuance discount